Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajing Du

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 19, 2024
Rapid elimination of scattering in three-dimensional fluorescence spectra via deep learningYuanyuan Yuan, Xinyue Liu, Xiaojian Wang, et al.
International Journal of Molecular Sciences|September 28, 2023
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor ProgressionXinbing Yang, Yajing Du, Lulu Luo, et al.
Oncology Letters|September 4, 2023
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinomaYuan Qu, Shan Xue, Yujian Zheng, et al.
Pharmaceutics|October 28, 2023
Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy DrugsYajing Du, Lulu Luo, Xinru Xu, et al.
Acta Biomaterialia|April 12, 2025
Engineered bioorthogonal cell delivery system for in situ antimicrobial peptide recruitment during systemic bacterial infectionWenchang Peng, Yun Fu, Yajing Du, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy StrategiesHaochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
International Immunopharmacology|August 24, 2020
Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinomaZhengyang Hu, Guoshu Bi, Qihai Sui, et al.
Journal of Cancer|April 15, 2021
Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung CancerMing Li, Zhencong Chen, Tian Jiang, et al.
Journal of Thoracic Disease|July 10, 2020
Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I-IIIA non-small cell lung cancer: a propensity-matched analysisJunjie Xi, Yajing Du, Zhengyang Hu, et al.
Life Sciences|January 31, 2021
Multi-omics characterization and validation of MSI-related molecular features across multiple malignanciesYuansheng Zheng, Yiwei Huang, Guoshu Bi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 19, 2024
Rapid elimination of scattering in three-dimensional fluorescence spectra via deep learningYuanyuan Yuan, Xinyue Liu, Xiaojian Wang, et al.
International Journal of Molecular Sciences|September 28, 2023
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor ProgressionXinbing Yang, Yajing Du, Lulu Luo, et al.
Oncology Letters|September 4, 2023
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinomaYuan Qu, Shan Xue, Yujian Zheng, et al.
Pharmaceutics|October 28, 2023
Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy DrugsYajing Du, Lulu Luo, Xinru Xu, et al.
Acta Biomaterialia|April 12, 2025
Engineered bioorthogonal cell delivery system for in situ antimicrobial peptide recruitment during systemic bacterial infectionWenchang Peng, Yun Fu, Yajing Du, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy StrategiesHaochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
International Immunopharmacology|August 24, 2020
Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinomaZhengyang Hu, Guoshu Bi, Qihai Sui, et al.
Journal of Cancer|April 15, 2021
Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung CancerMing Li, Zhencong Chen, Tian Jiang, et al.
Journal of Thoracic Disease|July 10, 2020
Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I-IIIA non-small cell lung cancer: a propensity-matched analysisJunjie Xi, Yajing Du, Zhengyang Hu, et al.
Life Sciences|January 31, 2021
Multi-omics characterization and validation of MSI-related molecular features across multiple malignanciesYuansheng Zheng, Yiwei Huang, Guoshu Bi, et al.
Pageof 3